David Sumerauer

4.8k total citations
48 papers, 443 citations indexed

About

David Sumerauer is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, David Sumerauer has authored 48 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in David Sumerauer's work include Glioma Diagnosis and Treatment (18 papers), Sarcoma Diagnosis and Treatment (12 papers) and Neuroblastoma Research and Treatments (8 papers). David Sumerauer is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Sarcoma Diagnosis and Treatment (12 papers) and Neuroblastoma Research and Treatments (8 papers). David Sumerauer collaborates with scholars based in Czechia, Germany and United States. David Sumerauer's co-authors include Roman Kodet, Zdeněk Sedláček, Lenka Krsková, Marie Trková, Marcela Mrhalová, Edita Kabíčková, Otakar Bělohlávek, Josef Zámečnı́k, Marie Hladíková and Martin Kynčl and has published in prestigious journals such as Blood, PLoS ONE and PEDIATRICS.

In The Last Decade

David Sumerauer

40 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sumerauer Czechia 12 171 125 123 119 107 48 443
Isabelle Quintin‐Roué France 13 123 0.7× 138 1.1× 130 1.1× 145 1.2× 49 0.5× 45 494
Valentina d’Escamard United States 7 228 1.3× 102 0.8× 159 1.3× 73 0.6× 41 0.4× 15 539
Hiroaki Sakamoto Japan 14 94 0.5× 176 1.4× 183 1.5× 70 0.6× 84 0.8× 49 559
Andreu Parareda Spain 10 126 0.7× 112 0.9× 115 0.9× 45 0.4× 154 1.4× 18 436
Georg Schwarzkopf Germany 11 249 1.5× 167 1.3× 155 1.3× 65 0.5× 87 0.8× 16 610
Vera Paulson United States 12 200 1.2× 98 0.8× 226 1.8× 59 0.5× 66 0.6× 43 710
Jun Watanabe Japan 11 208 1.2× 55 0.4× 72 0.6× 160 1.3× 95 0.9× 35 478
Suvendu Purkait India 15 266 1.6× 77 0.6× 82 0.7× 266 2.2× 128 1.2× 85 619
S.P. Hector Spain 11 121 0.7× 74 0.6× 81 0.7× 70 0.6× 241 2.3× 25 455
R. Haas Germany 13 173 1.0× 155 1.2× 95 0.8× 106 0.9× 75 0.7× 48 820

Countries citing papers authored by David Sumerauer

Since Specialization
Citations

This map shows the geographic impact of David Sumerauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sumerauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sumerauer more than expected).

Fields of papers citing papers by David Sumerauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sumerauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sumerauer. The network helps show where David Sumerauer may publish in the future.

Co-authorship network of co-authors of David Sumerauer

This figure shows the co-authorship network connecting the top 25 collaborators of David Sumerauer. A scholar is included among the top collaborators of David Sumerauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sumerauer. David Sumerauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumerauer, David, Lenka Krsková, Aleš Vícha, et al.. (2024). Clinical and molecular study of radiation-induced gliomas. Scientific Reports. 14(1). 3118–3118. 1 indexed citations
2.
Tomášek, Martin, Michal Zápotocký, David Sumerauer, et al.. (2023). Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors. Acta Neurochirurgica. 165(12). 4279–4292. 1 indexed citations
3.
Sumerauer, David, et al.. (2023). DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy. Child s Nervous System. 39(9). 2509–2513. 1 indexed citations
4.
Zápotocký, Michal, Jarmila Kruseová, David Sumerauer, et al.. (2022). Evaluation of the growth rates and related prognostic factors in radiation-induced meningiomas. Journal of Neuro-Oncology. 161(1). 155–163. 1 indexed citations
5.
Zápotocký, Michal, et al.. (2022). Current management in the treatment of intramedullary ependymomas in children. Child s Nervous System. 39(5). 1183–1192. 3 indexed citations
6.
Vícha, Aleš, Katerina Hadrava Vanova, David Sumerauer, et al.. (2022). Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas. Acta Neuropathologica Communications. 10(1). 143–143. 3 indexed citations
7.
Beneš, Vladimír, Michal Zápotocký, David Sumerauer, et al.. (2022). Survival and functional outcomes in paediatric thalamic and thalamopeduncular low grade gliomas. Acta Neurochirurgica. 164(6). 1459–1472. 8 indexed citations
8.
Baroni, Lorena, Daniel Alderete, Palma Solano‐Páez, et al.. (2020). Bevacizumab for pediatric radiation necrosis. Neuro-Oncology Practice. 7(4). 409–414. 13 indexed citations
9.
Morland, Bruce, Tomáš Kepák, Sandro Dallorso, et al.. (2020). Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC). Bone Marrow Transplantation. 55(9). 1744–1753. 19 indexed citations
10.
Petrák, B., et al.. (2019). Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1. Brain and Development. 41(8). 678–690. 13 indexed citations
11.
Švojgr, Karel, David Sumerauer, Alena Puchmajerová, et al.. (2015). Fanconi anemia with biallelic FANCD1/BRCA2 mutations – Case report of a family with three affected children. European Journal of Medical Genetics. 59(3). 152–157. 12 indexed citations
12.
Bartelheim, K., David Sumerauer, Uta Behrends, et al.. (2014). Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB). Cancer Genetics. 207(9). 379–383. 7 indexed citations
13.
Krsková, Lenka, et al.. (2009). Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. Cancer Genetics and Cytogenetics. 193(1). 1–8. 22 indexed citations
14.
15.
Sumerauer, David, Aleš Vícha, Lenka Krsková, et al.. (2006). Teratoma in an Adolescent With Malignant Transformation into Embryonal Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology. 28(10). 688–692. 6 indexed citations
16.
Kabíčková, Edita, et al.. (2006). Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 33(9). 1025–1031. 57 indexed citations
17.
Trková, Marie, Julie Fleitz, Anna Křepelová, et al.. (2005). Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. European Journal of Cancer. 41(11). 1597–1603. 54 indexed citations
18.
Vícha, Aleš, David Sumerauer, Roman Kodet, et al.. (2002). Malignant peripheral primitive neuroectodermal tumor of the kidney. Cancer Genetics and Cytogenetics. 139(1). 67–70. 12 indexed citations
19.
Sumerauer, David, et al.. (2001). Detection of Minimal Bone Marrow Infiltration in Patients with Localized and Metastatic Ewing Sarcoma Using RT-PCR. Folia Biologica. 47(6). 206–210. 6 indexed citations
20.
Kučerová, Hana, et al.. (2000). Gene Aberrations in Childhood Brain Tumors. Folia Biologica. 46(5). 187–190. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Quintin‐Roué Breakdown of academic impact, for papers by Valentina d’Escamard Breakdown of academic impact, for papers by Hiroaki Sakamoto Breakdown of academic impact, for papers by Andreu Parareda Breakdown of academic impact, for papers by Georg Schwarzkopf Breakdown of academic impact, for papers by Vera Paulson Breakdown of academic impact, for papers by Jun Watanabe Breakdown of academic impact, for papers by Suvendu Purkait Breakdown of academic impact, for papers by S.P. Hector Breakdown of academic impact, for papers by R. Haas
Rankless by CCL
2026